Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned

Published:2024-07 Issue:7 Volume:29 Page:104031
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Hogervorst Milou A.,van Hattem Christine C.,Sonke Gabe S.,Mantel-Teeuwisse Aukje K.,Goettsch Wim G.,Bloem Lourens T.

Publisher

Elsevier BV

Reference96 articles.

1. Tumour-agnostic therapies;Looney;Nat Rev Drug Discov,2020

2. Precision oncology: origins, optimism, and potential;Prasad;Lancet Oncol,2016

3. Pembrolizumab for all;Kim;J Cancer Res Clin Oncol,2023

4. European Public Assessment Report Rozlytrek;Committee for Medicinal Products for Human Use (CHMP),2020

5. European Public Assessment Report Vitrakvi;Committee for Medicinal Products for Human Use (CHMP),2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP